Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females

Table 7 sCD36 level variations according to the different polymorphisms

SNP CD36	Control	Type 2 Diabetes Mellitus	p value
rs1761667
GG	2145.13 ± 536.30	3415.64 ± 841.03	0.21
AA/AG	2943.04 ± 641.38	2609.80 ± 851.52	0.76
p value	0.35	0.50
rs3211867
CC	3889.34 ± 776.08	3880.58 ± 1081.11	0.99
AA/AC	1745.31 ± 432.49	2434.15 ± 676.63	0.40
p value	0.02*	0.27

SNP Single Nucleotide Polymorphism, sCD36 soluble CD36, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.0001

ISSN: 1755-8794